Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dupont, E. L.
Right arrow Articles by Reintgen, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dupont, E. L.
Right arrow Articles by Reintgen, D. S.
Related Collections
Right arrow Diagnosis
Annals of Surgical Oncology 8:354-360 (2001)
© 2001 Society of Surgical Oncology


ORIGINAL ARTICLES

The Role of Lymphoscintigraphy in the Management of the Patient With Breast Cancer

Elisabeth L. Dupont, MD, Vidyulata J. Kamath, Erik M. Ramnath, MS, Steven C. Shivers, PhD, Charles Cox, MD, Claudia Berman, MD, George S. Leight, Jr., MD, Merrick I. Ross, MD, Peter Blumencranz, MD and Douglas S. Reintgen, MD the DOD Breast Lymphatic Mapping Trial Investigators (Appendix A)

From the Comprehensive Breast Cancer Program, H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa, Florida, and DOD Breast Lymphatic Mapping Trial Member Institutions.

Correspondence: Correspondence to: Elisabeth L. Dupont, MD, H. Lee Moffitt Cancer Center, 12902 Magnolia Dr., Tampa, FL 33612-9497; Fax: 813-979-3984; E-mail: dupontel{at}moffitt.usf.edu

Introduction: Regional nodal status is the most powerful predictor of recurrence and survival in women with breast cancer. Lymphatic mapping and sentinel lymph node (SLN) biopsy have been found to accurately predict the regional nodal status. Preoperative lymphoscintigraphy has been used in melanoma patients to identify the basins at risk for metastases when primary sites are located in watershed areas of the body. This study was performed to define the role of lymphoscintigraphy for axillary nodal staging in women with breast cancer. Specifically, can preoperative lymphoscintigraphy define a population of women with breast cancer who have multidirectional drainage or who do not drain to the axilla and need no axillary dissection?

Methods: 516 patients with invasive breast cancer were accrued in a national breast lymphatic mapping trial sponsored by the U.S. Department of Defense. Preoperative lymphoscintigraphy images were produced using filtered technetium-99 sulfur colloid. Lymphatic drainage to axillary and internal mammary sites was noted.

Results: Drainage to an axillary SLN was found in 335 (65%) patients, and internal mammary or extra-axillary drainage was noted in 52 (10%) patients. By using sensitive hand-held probes and vital blue dye intraoperatively, the overall success rate of finding an axillary SLN was 85%. Of the 335 patients who had an axillary SLN identified with imaging, all had successful SLN biopsy procedures. Although no SLNs could be imaged in 181 patients, 153 (85%) of these patients had an axillary SLN identified with intraoperative mapping. For 28 patients in which lymphoscintigraphy was negative and intraoperative mapping was unsuccessful, complete axillary node dissection was performed, and 13 (46%) of these patients were found to have metastatic disease in the basin.

Conclusions: Preoperative lymphoscintigraphy can identify those women with primary breast cancers who have extra-axillary regional basin drainage such as internal mammary. The ability to image an axillary SLN was associated with a high success rate of being able to find the node intraoperatively with a combination mapping technique. In a high percentage of patients with negative lymphoscintigraphy, the SLN was identified with more sensitive hand-held probes. Therefore, patients who have a negative preoperative lymphoscintigraphy and intraoperatively are found to have no "hot" spot in the axilla with the hand-held probe still need an axillary node dissection, because 46% of these patients contain metastatic disease in the axilla.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
L. Wang, J.-m. Yu, Y.-s. Wang, W.-s. Zuo, Y. Gao, J. Fan, J.-y. Li, X.-d. Hu, M.-l. Chen, G.-r. Yang, et al.
Preoperative Lymphoscintigraphy Predicts the Successful Identification but Is Not Necessary in Sentinel Lymph Nodes Biopsy in Breast Cancer
Ann. Surg. Oncol., August 1, 2007; 14(8): 2215 - 2220.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
E. Dupont, C. E. Cox, K. Nguyen, C. J. Salud, E. S. Peltz, G. F. Whitehead, M. D. Ebert, N. Ni Ku, and D. S. Reintgen
Utility of Internal Mammary Lymph Node Removal When Noted by Intraoperative Gamma Probe Detection
Ann. Surg. Oncol., December 1, 2001; 8(10): 833 - 836.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society of Surgical Oncology.